Globus Medical, Inc.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprisin…

Medical - Devices

US, Audubon [HQ]

Financials

Analysts

Wall Street · Earnings · Institutional Sentiment

A comprehensive analysis section that covers unveiling insights about Globus Medical, Inc.'s gradings, price targets and earnings estimates.

Earnings

See the historical earnings and what wall street analysts forecasted and
forecast for future earnings.

Reported

Past Estimate Consensus

Future Estimate Consensus

EPS Revenue EBITDA EBIT SGA

All monetary values are presented in USD ($). E stands for Estimate.
FY	EPS		Revenue [mil.]		Profit [mil.]		EBITDA [mil.]		EBIT [mil.]		Expenses · SGA [mil.]
		E		E		E		E		E		E
2014	0.7400	0.810	434	428	68	81	167	142	124	122	182	167
2015	0.9800	1.081	474	543	92	105	171	182	144	160	187	199
2016	1.1900	1.196	544	561	112	103	173	192	160	153	214	224
2017	1.0900	1.276	563	629	104	102	202	195	159	153	222	262
2018	1.1200	1.626	635	708	107	127	212	178	166	139	267	264
2019	1.6000	1.715	712	784	156	160	226	233	176	178	311	382
2020	1.5700	1.357	785	786	155	46	229	132	176	45	354	441
2021	1.0400	2.021	789	951	102	118	182	202	115	136	354	337
2022	1.4800	2.031	958	1,024	149	156	289	274	194	187	408	421
2023	1.8900	2.308	1,022	1,559	190	40	313	302	236	205	432	463
2024	1.0900	2.858	1,568	2,483	122	327	401	689	201	501	643	1,073
2025	-	3.335	-	2,655	-	384	-	737	-	536	-	1,147
2026	-	3.861	-	2,836	-	2.F12X/td>	-	2.F121/td>	-	2.F121	-	2.F121
2027	-	4.393	-	3,045	-	1.F13X/td>	-	1.F131/td>	-	1.F131	-	1.F131
2028	-	4.880	-	3,312	-	0.F14X/td>	-	0.F141/td>	-	0.F141	-	0.F141

Institutional Sentiment

Wall Street · Earnings · Institutional Sentiment

The institutional sentiment measures the direction of new stock gradings
and price targets while comparing them Year-over-Year. We've limited the grading institutes to those we see as top-tier and update this data every month.

Morgan Stanley

1Y Ago:

Equal-Weight

Prev. Grade

Equal-Weight

Nov. 6, 2024

Equal-Weight

JP Morgan Chase

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

Citigroup

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

Overall Consensus

Here we aggregate the price targets and gradings of all IBs/AMCs/Brokerage firms inside our database to draw a bigger picture.

Grading Consensus

Click to each, to see the grade

Price Target Consensus

+3.71% + $3.14 · MISS

Nov. 6, 2024

Price Then

$75.58

Price Target

$81.58

Price Now

$84.72